New York 10/10/2013 12:44:02 AM
News / Finance

“Short Squeeze” May Lead to an Upward Price Spike in Arrayit Corporation Stock

Listonstreetpulse.com announces that a large percentage of Arrayit Corporation’s (OTC: ARYC) recent trading volume represents shorting and naked shorting. According to data from OTCshortreport.com, in the past 37 trading sessions, over 3 million shares of ARYC have been shorted, corresponding to 42.4% of the 7.1 million shares of ARYC traded. 

Based on a closing price calculation, the 3 million shorted shares of ARYC during the 37-day period represents a total of $1.2 million in short-selling transactions. The short selling activity involving ARYC shares can be accessed on-line at the following link: http://otcshortreport.com/index.php?index=ARYC&action=view#.UlSbnxyR15c. 

According to Investopedia.com, an on-line resource for investors, “A stock that has unusually high short interest and short interest ratio (SIR) may be at risk of a “short squeeze”, which may lead to an upward price spike. This is a constant risk that the short seller has to face. Apart from this risk of runaway losses, the short seller is also on the hook for dividends that may be paid by the shorted stock. In addition, for heavily shorted stocks there is a risk of a “buy in.” This refers to the fact that a brokerage can close out a short position at any time if the stock is exceedingly hard to borrow and the stock’s lenders are demanding it back.” 

The high short volume in ARYC coincides with record trading volume in the stock in the third quarter of 2013 and a 436% increase in ARYC stock price since July 17th. 

To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/

About Arrayit Corporation                            
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.

About Liston Street Pulse                                                 
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.